ADV-156,Rho A N19 (Dominant Negative) Recombinant Adenovirus,Cell Biolabs

Certainly! Here's a structured way to supplement and improve the product information for the Rho A N19 (Dominant Negative) Recombinant Adenovirus:


Product Information: Rho A N19 (Dominant Negative) Recombinant Adenovirus


Storage
- Temperature: Store at -80°C for optimal stability.
- Handling: Avoid repeated freeze-thaw cycles to preserve viral integrity.
- Shelf Life: When stored correctly, the product is stable for up to 12 months.
- Packaging: Provided in cryovials to ensure safe storage and handling.


Product Description
Rho A N19 (Dominant Negative) Recombinant Adenovirus is a genetically engineered viral vector designed to express a mutant form of the Rho A protein. This mutant acts as a dominant negative, effectively inhibiting the activity of endogenous Rho A, a small GTPase involved in various cellular functions including cytoskeletal organization, cell migration, and proliferation. This product is ideal for research applications where modulation of Rho A activity is desired.


Key Features
- Dominant Negative Mutation: Specifically inhibits Rho A signaling pathways.
- High Efficiency: Ensures robust expression in a wide range of cell types.
- Versatility: Suitable for in vitro and in vivo studies.
- Quality Control: Each batch is tested for viral titers and functional activity to ensure consistency and reliability.


What's Included
- Rho A N19 Recombinant Adenovirus: Provided in a specified concentration, typically measured in plaque-forming units (pfu).
- User Guide: Comprehensive instructions for use, including recommended protocols for transduction and troubleshooting tips.
- Safety Data Sheet (SDS): Detailed information on handling and potential hazards.
- Technical Support: Access to expert advice for experimental design and product use.


Applications
- Cell Signaling Studies: Explore the role of Rho A in cellular pathways.
- Cancer Research: Investigate the impact of Rho A inhibition on tumor cell behavior.
- Neuroscience: Study Rho A's involvement in neuronal development and regeneration.
- Cytoskeletal Research: Analyze changes in cell morphology and motility related to Rho A activity.
- Drug Development: Evaluate potential therapeutic targets involving Rho A pathways.

This improved product information aims to provide clear, concise details to assist researchers in understanding the capabilities and usage of the Rho A N19 (Dominant Negative) Recombinant Adenovirus.